{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Capmatinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Capmatinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Capmatinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "capmatinib",
    "trial_2_text": "Capmatinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Capmatinib Supplement: 60 participants will take Capmatinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Capmatinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Capmatinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.3883439004421234,
      "189": 0.2862170934677124,
      "188": 0.2695755958557129,
      "78": 0.2659170925617218,
      "123": 0.2561199367046356,
      "20": 0.21122919023036957,
      "64": 0.21001766622066498,
      "228": 0.19688831269741058,
      "17": 0.18154720962047577,
      "67": 0.15848810970783234,
      "37": 0.15809661149978638,
      "21": 0.1565966010093689,
      "173": 0.1502203643321991,
      "177": 0.14893971383571625,
      "9": 0.1469217985868454,
      "49": 0.14399957656860352,
      "200": 0.13345465064048767,
      "29": 0.132683664560318,
      "68": 0.13204945623874664,
      "46": 0.12833364307880402,
      "101": 0.12585334479808807,
      "77": 0.12261092662811279,
      "261": 0.12056520581245422,
      "350": 0.1190771609544754,
      "179": 0.1169654130935669,
      "136": 0.10971319675445557,
      "239": 0.10446559637784958,
      "191": 0.10062798112630844,
      "193": 0.09793879836797714,
      "243": 0.09712821245193481,
      "14": 0.09527049958705902,
      "114": 0.09521907567977905,
      "2": 0.09503808617591858,
      "126": 0.08975996822118759,
      "104": 0.08794941008090973,
      "131": 0.08563029766082764,
      "76": 0.08493663370609283,
      "30": 0.0843953862786293,
      "38": 0.08368995040655136,
      "257": 0.08341293781995773,
      "341": 0.0831374078989029,
      "249": 0.08271036297082901,
      "5": 0.08212664723396301,
      "194": 0.08047379553318024,
      "85": 0.08025380223989487,
      "79": 0.07993194460868835,
      "396": 0.07938557863235474,
      "130": 0.0790298730134964,
      "35": 0.07731625437736511,
      "27": 0.07643637806177139,
      "147": 0.07587122172117233,
      "343": 0.07243917137384415,
      "211": 0.0717880055308342,
      "61": 0.07171129435300827,
      "186": 0.07143885642290115,
      "355": 0.07068561762571335,
      "180": 0.07047601789236069,
      "72": 0.0696805939078331,
      "151": 0.06676255911588669,
      "82": 0.06560998409986496,
      "234": 0.06445082277059555,
      "269": 0.06420747935771942,
      "28": 0.06410429626703262,
      "288": 0.0638437494635582,
      "102": 0.06338278949260712,
      "122": 0.06182912737131119,
      "253": 0.06119544431567192,
      "282": 0.05890249088406563,
      "116": 0.05838403478264809,
      "454": 0.0576869361102581,
      "36": 0.057613804936409,
      "33": 0.05753285065293312,
      "356": 0.05730787292122841,
      "86": 0.05664628744125366,
      "204": 0.05572904646396637,
      "441": 0.05477957800030708,
      "212": 0.05463210865855217,
      "18": 0.052266933023929596,
      "276": 0.05187802016735077,
      "139": 0.050616487860679626,
      "96": 0.049407027661800385,
      "97": 0.048885975033044815,
      "371": 0.048783719539642334,
      "4": 0.04845071956515312,
      "422": 0.04841548949480057,
      "339": 0.04832633584737778,
      "69": 0.048130884766578674,
      "382": 0.04740334302186966,
      "164": 0.04724491760134697,
      "286": 0.04686252400279045,
      "466": 0.04676654189825058,
      "100": 0.04602782055735588,
      "99": 0.04488092288374901,
      "351": 0.0448104590177536,
      "98": 0.044342298060655594,
      "124": 0.04403870180249214,
      "142": 0.04403390362858772,
      "163": 0.04287081956863403,
      "213": 0.04268786683678627,
      "535": 0.0425952784717083
    },
    "trial_2_ae": {
      "87": 0.3883439004421234,
      "189": 0.2862170934677124,
      "188": 0.2695755958557129,
      "78": 0.2659170925617218,
      "123": 0.2561199367046356,
      "20": 0.21122919023036957,
      "64": 0.21001766622066498,
      "228": 0.19688831269741058,
      "17": 0.18154720962047577,
      "67": 0.15848810970783234,
      "37": 0.15809661149978638,
      "21": 0.1565966010093689,
      "173": 0.1502203643321991,
      "177": 0.14893971383571625,
      "9": 0.1469217985868454,
      "49": 0.14399957656860352,
      "200": 0.13345465064048767,
      "29": 0.132683664560318,
      "68": 0.13204945623874664,
      "46": 0.12833364307880402,
      "101": 0.12585334479808807,
      "77": 0.12261092662811279,
      "261": 0.12056520581245422,
      "350": 0.1190771609544754,
      "179": 0.1169654130935669,
      "136": 0.10971319675445557,
      "239": 0.10446559637784958,
      "191": 0.10062798112630844,
      "193": 0.09793879836797714,
      "243": 0.09712821245193481,
      "14": 0.09527049958705902,
      "114": 0.09521907567977905,
      "2": 0.09503808617591858,
      "126": 0.08975996822118759,
      "104": 0.08794941008090973,
      "131": 0.08563029766082764,
      "76": 0.08493663370609283,
      "30": 0.0843953862786293,
      "38": 0.08368995040655136,
      "257": 0.08341293781995773,
      "341": 0.0831374078989029,
      "249": 0.08271036297082901,
      "5": 0.08212664723396301,
      "194": 0.08047379553318024,
      "85": 0.08025380223989487,
      "79": 0.07993194460868835,
      "396": 0.07938557863235474,
      "130": 0.0790298730134964,
      "35": 0.07731625437736511,
      "27": 0.07643637806177139,
      "147": 0.07587122172117233,
      "343": 0.07243917137384415,
      "211": 0.0717880055308342,
      "61": 0.07171129435300827,
      "186": 0.07143885642290115,
      "355": 0.07068561762571335,
      "180": 0.07047601789236069,
      "72": 0.0696805939078331,
      "151": 0.06676255911588669,
      "82": 0.06560998409986496,
      "234": 0.06445082277059555,
      "269": 0.06420747935771942,
      "28": 0.06410429626703262,
      "288": 0.0638437494635582,
      "102": 0.06338278949260712,
      "122": 0.06182912737131119,
      "253": 0.06119544431567192,
      "282": 0.05890249088406563,
      "116": 0.05838403478264809,
      "454": 0.0576869361102581,
      "36": 0.057613804936409,
      "33": 0.05753285065293312,
      "356": 0.05730787292122841,
      "86": 0.05664628744125366,
      "204": 0.05572904646396637,
      "441": 0.05477957800030708,
      "212": 0.05463210865855217,
      "18": 0.052266933023929596,
      "276": 0.05187802016735077,
      "139": 0.050616487860679626,
      "96": 0.049407027661800385,
      "97": 0.048885975033044815,
      "371": 0.048783719539642334,
      "4": 0.04845071956515312,
      "422": 0.04841548949480057,
      "339": 0.04832633584737778,
      "69": 0.048130884766578674,
      "382": 0.04740334302186966,
      "164": 0.04724491760134697,
      "286": 0.04686252400279045,
      "466": 0.04676654189825058,
      "100": 0.04602782055735588,
      "99": 0.04488092288374901,
      "351": 0.0448104590177536,
      "98": 0.044342298060655594,
      "124": 0.04403870180249214,
      "142": 0.04403390362858772,
      "163": 0.04287081956863403,
      "213": 0.04268786683678627,
      "535": 0.0425952784717083
    }
  },
  "safety": {
    "trial_1_safety": 0.3533775806427002,
    "trial_2_safety": 0.3533775806427002
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4833335876464844
  }
}